EBOS Group Ltd
NZX:EBO
Gross Margin
EBOS Group Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| NZ |
|
EBOS Group Ltd
NZX:EBO
|
7B NZD |
13%
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
86.9B USD |
4%
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
55.4B USD |
3%
|
|
| US |
|
Cencora Inc
NYSE:COR
|
55.1B USD |
3%
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
31.9B USD |
3%
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
34.6B AUD |
7%
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
64.9B CNY |
32%
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
30%
|
|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
8.2B USD |
13%
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8B USD |
32%
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
53.1B CNY |
11%
|
EBOS Group Ltd
Glance View
In the sprawling landscape of the Australasian healthcare and animal care markets, EBOS Group Ltd. stands as a towering presence, orchestrating a symphony of operations that span distribution, logistics, and retail. Established decades ago, EBOS has meticulously expanded its footprint to become a vital linchpin in the supply chain of healthcare and animal care products. Understanding its core operations is akin to peering into a well-oiled machine where efficiency reigns supreme. At the heart of EBOS's business model is its distribution segment, which acts as a conduit for pharmaceutical and healthcare products from manufacturers to a diverse range of clients including hospitals, pharmacies, and aged care facilities. This seamless distribution network is supported by state-of-the-art logistics capabilities, enabling the company to ensure timely and reliable delivery of crucial healthcare supplies across the region. Beyond distribution, EBOS has judiciously diversified into animal care and retail, recognizing the intertwining of human and animal welfare in contemporary lifestyles. Its procurement and distribution of veterinary products capitalize on the robust and growing pet care market, which has seen a surge in demand as households increasingly consider pets as part of the family. The company's retail arm, featuring well-known banners like TerryWhite Chemmart, brings it closer to consumers, providing a direct link to end-users and fortifying its revenue streams. By embracing these complementary business segments, EBOS not only ensures a balanced portfolio but also leverages synergies to maximize profit margins. Thus, through a blend of comprehensive distribution networks and strategic retail positions, EBOS Group Ltd. adeptly maneuvers within its markets, translating efficiency and scale into consistent, sustainable growth.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on EBOS Group Ltd's most recent financial statements, the company has Gross Margin of 12.9%.
You don't have any saved screeners yet